ARCHIVES

President Signs Supplemental Funding For NIH And FDA.

This article is from The Cancer Letter archive.

Vol. 34 No. 27 | July 11, 2008

Download PDF Visit The Full Archive

Related Articles

Nexavar Improves PFS In Phase III Trial

January 25, 2013

FDA Approves Ribavirin Phase 102 Trials

October 30, 1987

Phase III Trial Shows Benefit For Old Drugs, Old Device, For Ovarian Cancer, But Will Practice Change?

January 20, 2006

Community Tobacco Control Intervention Grants Funded By NCI.

October 27, 2000

Centers Settle Into New Home, Face Old Problem; Five May Lose Grants, No Reprogramming Seen

November 17, 1989

NCCS Networker Volume 5 Issue 1, Winter 1991

January 13, 1991